Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH Mutations in Glioblastoma

• Daniel Krell ,

  Contributed equally to this work with: Daniel Krell, Mawuelikem Assoku

  Affiliations Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Medical Oncology, University College London Hospitals, London, United Kingdom

  ⨯
• Mawuelikem Assoku ,

  Contributed equally to this work with: Daniel Krell, Mawuelikem Assoku

  Affiliations Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom, Department of Medical Oncology, University College London Hospitals, London, United Kingdom

  ⨯
• Malcolm Galloway,

  Affiliation Department of Cellular Pathology, The Royal Free Hospital, London, United Kingdom

  ⨯
• Paul Mulholland,

  Affiliation Department of Medical Oncology, University College London Hospitals, London, United Kingdom

  ⨯
• Ian Tomlinson,

  Affiliation Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

  ⨯
• Chiara Bardella

  * E-mail: chiara.bardella@well.ox.ac.uk

  Affiliation Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom

  ⨯